|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 347.05 INR | -2.73% |
|
-2.75% | -15.73% |
| 07/03 | Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 100 million in funding from Aarti Drugs Limited | CI |
| 04/02 | Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026 |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 367.2 | 424.45 | 538.3 |
| Spread/Res. | -5.49% | -18.24% | -35.53% |
| Spread/Supp. | -0.50% | -0.50% | +5.47% |
| Support | 348.8 | 348.8 | 329.05 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AARTIDRUGS Stock
- Charts Aarti Drugs Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















